Optimal utilisation of biologic drugs in Behçet's Disease: a randomised controlled trial of infliximab vs alpha interferon, with genotyping and metabolomic profiling, towards a stratified medicines approach to treatment.
|III||Open||University of Liverpool||7|
0151 794 8974
Sorry there are currently no job vacancies
Some useful downloads: